|Year : 2017 | Volume
| Issue : 2 | Page : 72-76
Efficacy of single application of topical doxycycline hyclate and triamcinolone acetonide in denture adhesive in the management of recurrent aphthous stomatitis: A comparative study
Rakhi Chandak1, Sonal Sonule1, Manoj Chandak2, Shivlal Rawlani3, Romita Gaikwad1
1 Department of Oral Medicine and Radiology, Swargiya Dadasaheb Kalmegh Smurti Dental College and Hospital, Nagpur, Maharashtra, India
2 Department of Conservative Dentistry, Sharad Pawar Dental College, DMIMS, Sawangi (M), Wardha, Maharashtra, India
3 Department of Oral Medicine and Radiology, Sharad Pawar Dental College, DMIMS, Sawangi (M), Wardha, Maharashtra, India
|Date of Web Publication||26-Jul-2017|
Department of Oral Medicine and Radiology, Swargiya Dadasaheb Kalmegh Smurti Dental College and Hospital, Hingna Road, Wanadongri, Nagpur, Maharashtra
Source of Support: None, Conflict of Interest: None
Aim: This study aims to evaluate the efficacy of single application of topical doxycycline hyclate and triamcinolone acetonide only once as a new therapeutic regimen in the management of recurrent aphthous stomatitis for pain reduction.
Materials and Methods: A total of 30 patients were included among which 15 patients were taken into each group. Patients with aphthous ulcer were diagnosed on clinical examination, pain intensity was noted using a visual analog scale (VAS) of 0–10 (with 1 mm division, where “0” is no pain and “10” is worst possible pain), number of ulcers, size of each ulcer, and the duration of each ulcer were recorded. Group I was treated with doxycycline hyclate fine powder mixed in denture adhesive and applied onto the lesion. Group II was treated with 0.1% triamcinolone acetonide gel mixed in denture adhesive and applied onto the lesion. A pain scale sheet was given to each patient to self-evaluate the daily status of pain scale on the day after treatment and daily after that for 7 days.
Results: Pain intensity on VAS scale in Group I was 4.27 before treatment and 2.27 after treatment. Similarly, in Group II was 3.60 before treatment and 2.13 after treatment. Pain reduction in VAS-after treatment in 15 Group I patients was 46.8% after treatment on day 1. Moreover, in Group II was 40.8% after treatment on day 1. Group I had faster ulcer healing 2.87 ± 0.743 days when compared to Group II 5.13 ± 0.915 days with the P value of (<0.001).
Conclusion: Healing of the ulcer was significantly faster with doxycycline treatment compared to triamcinolone ointment with no adverse effects. Doxycycline is proved to be one of the modalities for the treatment of aphthous ulcer.
Keywords: Aphthous ulcer, denture adhesive, doxycycline hyclate, triamcinolone acetonide
|How to cite this article:|
Chandak R, Sonule S, Chandak M, Rawlani S, Gaikwad R. Efficacy of single application of topical doxycycline hyclate and triamcinolone acetonide in denture adhesive in the management of recurrent aphthous stomatitis: A comparative study. J Oral Res Rev 2017;9:72-6
|How to cite this URL:|
Chandak R, Sonule S, Chandak M, Rawlani S, Gaikwad R. Efficacy of single application of topical doxycycline hyclate and triamcinolone acetonide in denture adhesive in the management of recurrent aphthous stomatitis: A comparative study. J Oral Res Rev [serial online] 2017 [cited 2022 Aug 16];9:72-6. Available from: https://www.jorr.org/text.asp?2017/9/2/72/211636
| Introduction|| |
Recurrent aphthous ulcers (RAUs) affect 20% of the population and are currently one of the most common oral disorders. Recurrent aphthous stomatitis (RAS) is an inflammatory condition of unknown etiology characterized by recurrent, painful, single, or multiple ulcerations of the oral mucosa.
Most of the studies have failed to find the exact etiology and pathophysiology of RAS. Heredity, hematologic deficiencies, immune dysregulation, stress, local trauma, mechanical injury, hormonal disturbances, some foods, drugs, infections, smoking habits, and poor oral hygiene can be the predisposing factors., It has been suggested that interstitial collagenases (matrix metalloproteinase-1 [MMP-1] and MMP-8) play a major role in tissue destructive events in RAU.,,
Various treatment modalities such as anti-inflammatory agents, steroids, sucralfate, tetracycline suspension, analgesics, anesthetics, antiseptics, and silver nitrate which are the standard topical treatment options that provide symptomatic relief. Beneficial results are obtained with topical or systemic steroids for some subjects. Many therapeutic options are available either to cure or reduce the duration of recurrences but in all current therapy does not provide a satisfactory means for curing aphthous stomatitis, moreover, their clinical value remains unproven.,,,,, Since 1960, local regimens of tetracycline have been used in the treatment of RAU based on its antimicrobial property. However, newer properties of doxycycline such as leukocyte suppression, inhibition of prostaglandin production, and inhibition of collagenase and gelatinase have further promoted its use in the management of RAU as an effective modality.,,,
Recently, tissue adhesives have been preferred in the treatment of RAU, as it is having property to keep the medication attached in close contact with the ulcer as long as possible. Therefore, the aim of the present study is to evaluate the efficacy of topical application of doxycycline hyclate in comparison with triamcinolone acetonide only once as a new therapeutic regimen in the treatment of minor RAU for pain reduction.
| Materials and Methods|| |
The study was conducted in the Department of Oral Medicine and Radiology after approval by institutional ethical committee. This study included a total of 30 patients which were divided into four groups each of 15 patients.
Group I: 15 patients receiving doxycycline hyclate 100 mg tablets (Doxt 100).
Group II: 15 patients receiving 0.1% triamcinolone acetonide paste (Ulcilone 5 g) manufactured by Helios Pharmaceuticals.
The sample was selected randomly those who came in Oral Medicine and Radiology Department. Males and female adult outpatients with age ranging from 15 to 40 years, 16 females and 14 were males; age group was not matched among both groups.
Patients were enrolled in the study after clinical examination and documentation of clinical history. Healthy controls were included with a history of the duration of ulcers for more than 24 h and not exceeding 72 h with symptoms and ulcers with the characteristic clinical features of recurrent minor oral aphthous were included in the study. The exclusion criteria were (i) pregnant and lactating women, (ii) existing other oral mucosal diseases, (iii) hematologic abnormalities, (iv) history of hypersensitivity to tetracycline, (v) end-stage renal disease, or (vi) those taking any other medications for an oral aphthous ulcer.
Clinical examination was carried out using sterile hand gloves and mask. Detail case history, with patient's informed consent, was taken. Treatment was administered on the day of the initial visit. A diagnosis of aphthous ulcer was made when it occurred in the nonkeratinized mucosa as a shallow crateriform ulcer covered by a whitish yellow pseudomembrane and presented with a round, regular border with a surrounding erythematous halo. On clinical examination, pain intensity using a visual analog scale (VAS) of 0–10 (with 1 mm division, where “0” is no pain and “10” is worst possible pain), number of ulcers, size of each ulcer (a graduated periodontal probe was used to measure the ulcer size at the maximum diameter of the ulcer), and the duration of each ulcer (the day of onset of the first prodromal symptom of each ulcer) were recorded. After complete clinical examination of the ulcer, pretreatment photographs were taken before the start of treatment. The ulcer and the mucosa surrounding the ulcer were dried thoroughly. Cotton rolls were placed for isolation.
In Group I, [Figure 1] doxycycline hyclate was ground to fine powder using a glass mortar and pestle. An appropriate amount of the medicament was mixed with a pinch of denture adhesive and few drops of saline in a glass slab using a stainless steel cement spatula. Then, the final mixture was placed over the ulcer using a plastic instrument. Similarly, in Group II, [Figure 2] 0.1% triamcinolone acetonide was mixed in denture adhesive and applied onto the lesion in a similar manner. After topically applying the medicament over the ulcer in each group it was allowed to dry within few minutes with the chip syringe, the patient was asked to refrain from eating or drinking for 2 h. The patient was recalled after 3 days following the treatment procedure. A pain scale sheet to record the daily status of the pain was given at the initial visit. The patients were instructed to self-evaluate the pain scale sheet on the day after treatment and daily after that for 3 days and also to note any adverse effects with the medication. After 3 days, the patients were asked to return the pain scale record.
|Figure 1: (a) Doxycycline hyclate group-pretreatment, (b) application of doxycycline hyclate to the ulcer, and (c) doxycycline hyclate group posttreatment|
Click here to view
|Figure 2: (a) triamcinolone acetonide group-pretreatment, (b) application of triamcinolone acetonide to the ulcer, and (c) triamcinolone acetonide group posttreatment|
Click here to view
| Results|| |
Data were tabulated, statistical analysis was done, and results were obtained. In the present study, out of 30 patients 16 were females and 14 were males with age ranging from 15 to 40 years. Out of 15 patients in Group I had 17 ulcers, out of which 2 patients had 2 ulcers. There were 15 ulcers in Group II patients.
Pain intensity on VAS scale in 15 Group I patients was 4.27 ± 1.387 before treatment on day 1 and immediately after treatment was 2.27 ± 1.163 on day 1 and subsequently 1.13 ± 0.990 on day 2 and 0.53 ± 0.640 on day 3. Pain reduction in VAS-after treatment in 15 Group I patients was 46.8% after treatment on day 1; 73.5% on day 2; 87.6% on day 3 [Table 1]. The average number of days for individuals in Group I to heal ulcer was 2.87 ± 0.743 days. There was statistically significant difference with the P < 0.001 noted in Group I in pain intensity by VAS scale and percentage of pain reduction.
|Table 1: Pain incidence and pain reduction by visual analog scale before and after treatment when compared individually|
Click here to view
Similarly, in Group II, the pain intensity was 3.60 ± 1.502 before treatment and 2.13 ± 1.302 after treatment on day 1; 1.33 ± 0.816 on day 2; 0.40 ± 0.507 on day 3. Pain reduction in VAS-after treatment in 15 in Group II was 40.8% after treatment on day 1; 63.1% on day 2; 88.9% on day 3 [Table 1]. The average number of days for individuals in Group II to heal ulcer was 5.13 ± 0.915 days. There was statistically significant difference with the P < 0.001 was noted in Group II in pain intensity by VAS scale and percentage of pain reduction.
When Group I and II were compared together, there was no statistically significant difference in pain intensity by VAS scale [Table 2] and there was no statistically significant difference in pain reduction in ulcer healing between both groups [Figure 3]. Days required for ulcer healing was significantly faster in doxycycline group when compared triamcinolone group [Table 3]. None of the patients in our study reported any serious adverse effects because of the study drugs.
|Table 2: Pain incidence by visual analog scale before and after treatment when both groups compared together|
Click here to view
| Discussion|| |
RAUs or aphthous stomatitis is a disorder characterized by recurring ulcers confined to the oral mucosa in patients with no other signs of disease. RAS is classified according to clinical characteristics: Minor ulcers, major ulcers (Sutton's disease, periadenitis mucosa necrotica recurrens), and herpetiform ulcers. Minor ulcers, which comprise over 80% of RAS cases, are less than 1 cm in diameter and heal without scars within a week. Major ulcers, are over 1 cm in diameter and take longer to heal over 10–14 days and often scar. Herpetiform ulcers are considered a distinct clinical entity that manifests as recurrent crops of dozens of small ulcers throughout the oral mucosa.
The first episodes of RAS most frequently begin during the second decade of life and may be precipitated by minor trauma, menstruation, upper respiratory infections, or contact with certain foods. The lesions are confined to the oral mucosa and begin with prodromal burning any time from 2 to 48 h before an ulcer appears. During this initial period, a localized area of erythema develops. Within hours, a small white papule forms ulcerates, and gradually enlarges over the next 48–72 h. The individual lesions are round, symmetric, and shallow (similar to viral ulcers), but no tissue tags are present from ruptured vesicles this helps to distinguish RAS from disease with irregular ulcers such as erythema multiforme, pemphigus, and pemphigoid. The buccal and labial mucosa are most commonly involved. Lesions are less common on the heavily keratinized palate or gingiva.
A significantly reduction in the pain intensity of RAU was found in the group of patients with doxycycline group as well as triamcinolone group when compared together. The intensity of the pain was statistically reduced on the very 1st day after treatment almost immediately after application of the medication. This indicates that treatment with doxycycline is as effective as triamcinolone in treating an aphthous ulcer.
In the present study, pain relief was achieved with doxycycline treatment was effective compared with the study by Gorsky et al. conducted a crossover trial to assess the efficacy of 0.2% minocycline and 0.25% tetracycline oral rinses in patients with frequent episodes of RAS. Minocycline mouthwashes as compared with topical tetracycline rinses resulted in significantly improved pain control, by reducing the severity and duration of pain. Another study by Preshaw et al. used subantimicrobial dose of doxycycline 20 mg to prevent the recurrence of RAS. In this study, we used powder of doxycycline mixed in denture adhesive mixed in saline in applied onto the ulcer.
Vijayabala et al. conducted a study on topical doxycycline hyclate powder mixed in denture adhesive was applied on an aphthous ulcer in which doxycycline hyclate patients had significantly less pain by day 1 (P < 0.001) and healed faster (P < 0.001) compared with placebo. In the present study, Group I patients had significantly less pain by day 1 and also ulcer healed faster when compared with Group II patients.
Pain relief with doxycycline may be due to the recently recorded nonantimicrobial properties of doxycycline molecules. Recent studies indicate that MMPs may play an important role in tissue destruction in aphthous ulcers and the effect of tetracyclines helps to inhibit human MMP., Doxycyclines may also reduce the amount of some MMP proteins present in the tissue. An additional nonantimicrobial property of doxycyclines that may be relevant to inflammation cell-mediated tissue destruction line in RAU is their ability to suppress neutrophil function and to scavenge reactive oxygen species.
In the present study, pain relief achieved with the triamcinolone acetonide mixed in denture adhesive group in a similar fashion as that of doxycycline group compared with the study by Miles et al. where topical steroid triamcinolone acetonide combined with cyanoacrylate barrier was used as the local medication.
From the present study, it was evident that the vehicle used in our study denture adhesive showed some beneficial effect with the fact that any topical medication in the oral cavity can be retained for a longer time with the help of tissue adhesive material used. The pain reduction in both groups was quite similar when both groups were compared together, the only difference being that the ulcer healed faster in doxycycline group when compared to triamcinolone acetonide group.
| Conclusion|| |
Healing of the ulcer was significantly faster for the doxycycline group compared to triamcinolone ointment. No significant difference in the speed of pain reduction between the doxycycline and triamcinolone ointment. The doxycycline was found to be equally effective in treating oral aphthous ulceration, with some advantage over the widely used preparation triamcinolone ointment. It appears advantageous because of its cost-effectiveness, single application, and faster symptomatic relief than other drugs.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Besu I, Jankovic L, Magdu IU, Konic-Ristic A, Raskovic S, Juranic Z. Humoral immunity to cow's milk proteins and gliadin within the etiology of recurrent aphthous ulcers? Oral Dis 2009;15:560-4.
Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Häyrinen-Immonen R. Recurrent aphthous ulcers today: A review of the growing knowledge. Int J Oral Maxillofac Surg 2004;33:221-34.
Koybasi S, Parlak AH, Serin E, Yilmaz F, Serin D. Recurrent aphthous stomatitis: Investigation of possible etiologic factors. Am J Otolaryngol 2006;27:229-32.
Wray D, Graykowski EA, Notkins AL. Role of mucosal injury in initiating recurrent aphthous stomatitis. Br Med J (Clin Res Ed) 1981;283:1569-70.
Ylikontiola L, Sorsa T, Häyrinen-Immonen R, Salo T. Doxymycine-cyanoacrylate treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:329-33.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al.
Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
Weiss SJ. Tissue destruction by neutrophils. N
Engl J Med 1989;320:365-76.
de Abreu MA, Hirata CH, Pimentel DR, Weckx LL. Treatment of recurrent aphthous stomatitis with clofazimine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:714-21.
Rees TD, Binnie WH. Recurrent aphthous stomatitis. In: Miles DA, Rogers RS, editors. Dermatologic Disorders Affecting the Oral Cavity. Philadelphia: WB Saunders; 1996.
Vincent SD, Lilly GE. Clinical, historic, and therapeutic features of aphthous stomatitis. Literature review and open clinical trial employing steroids. Oral Surg Oral Med Oral Pathol 1992;74:79-86.
Neville BW, Datum DD, Allen CM, Bouquot JE. Oral and Maxillofacial Pathology. Philadelphia: WB Saunders Co.; 1995. p. 236-55.
Drinnan AJ, Fischman SL. Controversies in oral medicine. Dent Clin North Am 1990;34:159-69.
Cook BE. The diagnosis of bullous lesions affecting the oral mucosa. I. Br Dent J 1960;109:83-96.
Golub LM, Ciancio S, Ramamamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-30.
Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, et al.
Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N
Y Acad Sci 1994;732:112-31.
Lauhio A, Salo T, Tjäderhane L, Lähdevirta J, Golub LM, Sorsa T. Tetracyclines in treatment of rheumatoid arthritis. Lancet 1995;346:645-6.
Vijayabala GS, Kalappanavar AN, Annigeri RG, Sudarshan R, Shettar SS. Single application of topical doxycycline hyclate in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:440-6.
Woo SB, Greenberg MS. Ulcerative, vesicular, and bullous lesions. In: Greenberg MS, Glick M, editor. Burket' s Oral Medicine. Hamilton: BC Decker Inc.; 2008. p. 50-84.
Gorsky M, Epstein J, Rabenstein S, Elishoov H, Yarom N. Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: A randomized cross-over study. Dermatol Online J 2007;13:1.
Preshaw PM, Grainger P, Bradshaw MH, Mohammad AR, Powala CV, Nolan A. Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: A pilot study. J Oral Pathol Med 2007;36:236-40.
Miles DA, Bricker SL, Razmus TF, Potter RH. Triamcinolone acetonide versus chlorhexidine for treatment of recurrent stomatitis. Oral Surg Oral Med Oral Pathol 1993;75:397-402.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Dissolvable and layered microneedles composed of hyaluronate/rbFGF/CPC effectively improve the treatment effect on recurrent aphthous ulcers
| ||Zhengrong Yin, Xiangli Zhang, Yan Bai, Yanwei Yang, Bin Liu, Zengjie Fan |
| ||New Journal of Chemistry. 2022; |
|[Pubmed] | [DOI]|
||Single application of topical doxycycline in management of recurrent aphthous stomatitis: a systematic review and meta-analysis of the available evidence
| ||Sadeq Ali Al-Maweri,Esam Halboub,Sajna Ashraf,Ahmed Y. Alqutaibi,Nashwan Mohammed Qaid,Kamila Yahya,Mohammed Nasser Alhajj |
| ||BMC Oral Health. 2020; 20(1) |
|[Pubmed] | [DOI]|